Clinical Trials
PSA No longer Responds to Androgen Deprivation Treatment (CRPC)

This Information is provided to help patients identify clinical trials for educational purposes and not to recruit patients for any specific trials. Patients should consult with their personal doctor and the trial sponsors for additional information on trials of interest.

Study of a Monoclonal Antibody and Ketoconazole in Patients with Prostate Cancer

Number: NCT00859781
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Weill Medical College of Cornell University
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study Comparing CyberKnife Surgery with Brachytherapy in Prostate Cancer Patients

Number: NCT01045148
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): CyberKnife Centers of San Diego
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of an Antidepressant in Treating Patients With Non-metastatic Recurrent Prostate Cancer

Number: NCT02217709
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Southern California|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease

Number: NCT02663908
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: 3
Sponsor(s): Ferring Pharmaceuticals|Memorial Sloan Kettering Cancer Center|Duke Clinical Research Institute
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of a Combination Therapy in Patients With Prostate Cancer

Number: NCT02796898
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Tyme, Inc
Sponsor Trial Information
Trial Location(s) and Contact(s)
Clinical Study of change in brain structure or activity in men treated with androgen receptor therapies such as abiraterone acetate and enzalutamide

Number: NCT03016741
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 4
Sponsor(s): Northwestern University
Sponsor Trial Information
Trial Location(s) and Contact(s)
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Number: NCT04060342
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1/2
Sponsor(s): Grossamer Bio, Inc
Sponsor Trial Information
Trial Location(s) and Contact(s)

Total: 7 Clinical Trials



PHEN,Inc. © 2019 All rights reserved